A Wealth of Experience
We have collaborated with our clients on projects to research gastrointestinal (GI) disease, GI treatment, and complications and comorbidities of GI disease.
Our experience includes:
- Celiac disease
- Chronic idiopathic constipation
- Crohn’s disease
- Diverticulitis
- Dyspepsia
- Gastroesophageal reflux disease (GERD)
- Pediatric GERD
- Gastroparesis
- Gastric cancer
- Irritable bowel syndrome (IBS) (diarrhea-predominant & constipation-predominant)
- Opioid-induced constipation
- Postoperative ileus
- Ulcerative colitis
Types of Projects
We have implemented studies to help our clients develop strategies in the gastrointestinal (GI) market and to develop and gain market access for products to treat GI diseases and complications arising from treatment of GI illnesses. Recent projects have included:
- Benefit-risk preference studies
- Cohort and case-control studies
- Consulting on drug development from preclinical through postmarketing
- Decision-analytic models (cost effectiveness, budget impact, Markov)
- Drug utilization studies
- Economic burden of illness studies
- Exploratory analyses of clinical trial data
- Global Value Dossiers
- Health care resource utilization studies
- Literature reviews
- Payer research
- Patient-reported outcomes (PRO) studies (including instrument development, evaluation, and validation)
- Psychometric evaluations of PRO instruments
- Qualitative physician and patient research
- Reimbursement and value communication strategies
- Risk management programs including development, implementation, and evaluation
- Survey development, evaluation and implementation